Coronary heart disease in a patient with cerebrotendinous xanthomatosis
- PMID: 15147532
- DOI: 10.1111/j.1365-2796.2004.01316.x
Coronary heart disease in a patient with cerebrotendinous xanthomatosis
Abstract
Coronary heart disease is a prevalent condition and a leading cause of death in developed countries. Most cases are due to the cluster of classical risk factors, such as smoking, diabetes, high blood pressure and dyslipidaemia. However, a few patients develop severe and premature arteriosclerosis in spite of absence of common risk factors. Here, we present the clinical, analytical and molecular features of a 36-years-old man who died from advanced ischaemic heart disease as a result of cerebrotendinous xanthomatosis (CTX), a rare condition characterized by elevation in plasma and most tissues of cholestanol and where neurological impairment is the hallmark of this disease. We discuss the relevance of heart disease and the mechanism leading to accelerate arteriosclerosis is CTX.
Similar articles
-
Cerebrotendinous xanthomatosis: a treatable cause of metabolic ataxia.J Assoc Physicians India. 2007 Sep;55:655-7. J Assoc Physicians India. 2007. PMID: 18051740
-
Cerebrotendinous xanthomatosis in three siblings from a Chinese family.Singapore Med J. 2001 Jan;42(1):30-2. Singapore Med J. 2001. PMID: 11361235
-
Inherited cholesterol lipidosis: cerebrotendinous xanthomatosis (van Bogaert Scherer Epstein disease). A clinicopathological study.Clin Neuropathol. 2005 Nov-Dec;24(6):276-83. Clin Neuropathol. 2005. PMID: 16320823
-
'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.Rheumatology (Oxford). 2005 Dec;44(12):1492-502. doi: 10.1093/rheumatology/kei142. Epub 2005 Oct 18. Rheumatology (Oxford). 2005. PMID: 16234277 Review.
-
Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.Circulation. 2007 May 15;115(19):2549-69. doi: 10.1161/CIRCULATIONAHA.107.182615. Circulation. 2007. PMID: 17502590 Review.
Cited by
-
Natural history of neurological abnormalities in cerebrotendinous xanthomatosis.J Inherit Metab Dis. 2018 Jul;41(4):647-656. doi: 10.1007/s10545-018-0152-9. Epub 2018 Feb 26. J Inherit Metab Dis. 2018. PMID: 29484516 Review.
-
Pathophysiology and Treatment of Lipid Abnormalities in Cerebrotendinous Xanthomatosis: An Integrative Review.Brain Sci. 2023 Jun 22;13(7):979. doi: 10.3390/brainsci13070979. Brain Sci. 2023. PMID: 37508912 Free PMC article. Review.
-
Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments.J Atheroscler Thromb. 2021 Sep 1;28(9):905-925. doi: 10.5551/jat.RV17055. Epub 2021 May 8. J Atheroscler Thromb. 2021. PMID: 33967188 Free PMC article.
-
Rapidly progressive dementia and intractable diarrhea: a teaching case report and a systematic review of cognitive impairment in Whipple's disease.Neurol Sci. 2022 Feb;43(2):907-926. doi: 10.1007/s10072-021-05844-5. Epub 2022 Jan 3. Neurol Sci. 2022. PMID: 34981284 Free PMC article. Review.
-
Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies.Mol Genet Metab. 2017 Sep;122(1-2):18-32. doi: 10.1016/j.ymgme.2017.08.006. Epub 2017 Aug 20. Mol Genet Metab. 2017. PMID: 28863857 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources